Birgit Geoerger Selected Research

Familial ependymoma

7/2008	EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts.
5/2006	p53 Pathway dysfunction in primary childhood ependymomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Birgit Geoerger Research Topics

Disease

108	Neoplasms (Cancer) 05/2024 - 02/2002
20	Neuroblastoma 03/2024 - 11/2008
16	Glioma (Gliomas) 01/2023 - 02/2002
12	Rhabdomyosarcoma 11/2023 - 02/2007
9	Brain Neoplasms (Brain Tumor) 07/2023 - 03/2004
8	Medulloblastoma 07/2023 - 01/2008
8	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 12/2011
6	Neoplasm Metastasis (Metastasis) 12/2017 - 12/2010
5	Thrombocytopenia (Thrombopenia) 12/2023 - 02/2007
5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2023 - 01/2018
5	Ewing Sarcoma (Sarcoma, Ewing) 01/2023 - 12/2011
4	Osteosarcoma (Osteogenic Sarcoma) 01/2023 - 08/2014
4	Lymphoma (Lymphomas) 01/2023 - 10/2019
4	Carcinogenesis 03/2017 - 07/2008
4	Ependymoma 03/2015 - 05/2006
3	Neutropenia 12/2023 - 02/2007
3	Vomiting 01/2023 - 02/2007
3	Disease Progression 01/2020 - 01/2012
3	Nausea 01/2020 - 02/2007
3	Glioblastoma (Glioblastoma Multiforme) 03/2015 - 10/2002
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2020
2	Leukemia 01/2023 - 01/2020
2	Diarrhea 01/2023 - 02/2007
2	Central Nervous System Neoplasms 01/2022 - 01/2020
2	Rhabdoid Tumor (Rhabdoid Tumors) 07/2021 - 05/2017
2	Hypoxia (Hypoxemia) 10/2020 - 03/2004
2	Melanoma (Melanoma, Malignant) 01/2020 - 11/2017
2	Hodgkin Disease (Hodgkin's Disease) 01/2020 - 01/2020
2	Alveolar Rhabdomyosarcoma 01/2018 - 02/2016
2	Fatigue 05/2017 - 12/2016
2	Anemia 12/2016 - 02/2007
2	Diffuse Intrinsic Pontine Glioma 07/2015 - 01/2012
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2015 - 11/2008
2	Astrocytoma (Pilocytic Astrocytoma) 01/2013 - 07/2007
2	Body Weight (Weight, Body) 07/2011 - 11/2008

Drug/Important Bio-Agent (IBA)

11	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 10/2010
10	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2010
9	RNA (Ribonucleic Acid)IBA 02/2024 - 10/2020
7	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 02/2007
7	Anaplastic Lymphoma KinaseIBA 01/2023 - 01/2018
7	Tyrosine Kinase InhibitorsIBA 01/2023 - 02/2008
6	Vincristine (Oncovin)FDA LinkGeneric 11/2023 - 02/2016
6	Phosphotransferases (Kinase)IBA 07/2023 - 02/2016
6	Topotecan (Hycamtin)FDA LinkGeneric 11/2021 - 10/2010
5	CrizotinibIBA 01/2023 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2017
4	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2015
4	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 08/2004
4	dabrafenibIBA 01/2023 - 12/2019
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2008
4	Bevacizumab (Avastin)FDA Link 11/2021 - 01/2017
3	AntibodiesIBA 03/2024 - 01/2008
3	NivolumabIBA 01/2024 - 01/2018
3	regorafenibIBA 11/2023 - 01/2015
3	TropomyosinIBA 07/2023 - 12/2021
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 09/2017
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 10/2012
3	AntigensIBA 01/2023 - 01/2020
3	trametinibIBA 01/2023 - 01/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2017
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2015
3	larotrectinibIBA 01/2022 - 01/2020
3	Sirolimus (Rapamycin)FDA Link 11/2021 - 06/2011
3	sonidegibIBA 01/2021 - 02/2015
3	Alanine Transaminase (SGPT)IBA 01/2020 - 07/2011
3	Monoclonal AntibodiesIBA 08/2014 - 12/2010
3	Insulin-Like PeptidesIBA 12/2011 - 12/2010
2	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 09/2008
2	Cell-Free Nucleic AcidsIBA 07/2023 - 01/2022
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 01/2023
2	atezolizumabIBA 01/2023 - 01/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 05/2011
2	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 01/2017
2	tyrosine receptor (receptor, tyrosine)IBA 12/2021 - 01/2019
2	Everolimus FDA Link 11/2021 - 01/2013
2	ribociclibIBA 11/2021 - 05/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2021 - 01/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2021 - 02/2008
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020 - 12/2016
2	BI 6727IBA 01/2019 - 02/2016
2	cabozantinibIBA 01/2017 - 07/2015
2	Axitinib (AG 013736)IBA 01/2017 - 06/2011
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2015 - 01/2015
2	dipinacoline glutamateIBA 07/2015 - 01/2012
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2015 - 04/2009
2	ParaffinIBA 02/2015 - 01/2012
2	teprotumumabIBA 08/2014 - 12/2011
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2011 - 01/2011
2	Cytochrome P-450 CYP3AIBA 07/2011 - 11/2008
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2011 - 09/2008
2	Imatinib Mesylate (Gleevec)FDA Link 09/2009 - 11/2008

Therapy/Procedure

40	Therapeutics 05/2024 - 10/2002
23	Investigational Therapies (Experimental Therapy) 05/2024 - 09/2009
13	Drug Therapy (Chemotherapy) 03/2024 - 05/2006
10	Precision Medicine 01/2024 - 01/2017
8	Radiotherapy 11/2022 - 10/2002
4	Immunotherapy 03/2024 - 06/2014
4	Injections 05/2005 - 02/2002
2	Salvage Therapy 01/2022 - 01/2011